Prosecution Insights
Prosecution Insights
16 pending office actions • 12 art units • 15 examiners • 0 of 16 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 15 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 15 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (6%) |
| §103 only | 5 (31%) |
| §112 only | 3 (19%) |
| No statute on record | 7 (44%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SZPERKA, MICHAEL EDWARD | 2 | 62.5% | +37.6% |
| RONEY, CELESTE A | 1 | 62.3% | +18.0% |
| WORSHAM, JESSICA N | 1 | 56.6% | +57.0% |
| NATARAJAN, MEERA | 1 | 62.2% | +16.8% |
| RAMIREZ, DELIA M | 1 | 65.0% | +56.5% |
| BRISTOL, LYNN ANNE | 1 | 63.7% | +39.7% |
| BERHANE, SELAM | 1 | 61.3% | +55.5% |
| FAN, LYNN Y | 1 | 46.6% | +49.1% |
| SEITZ, ANTHONY JOSEPH | 1 | 68.8% | +28.3% |
| MARCSISIN, ELLEN JEAN | 1 | 32.8% | +48.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18219138 | ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS | NATARAJAN, MEERA | 38d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18011807 | DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATING PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) IN PEDIATRIC PATIENTS | BERHANE, SELAM | 73d overdue |
| 18029525 | METHODS OF TREATING DERMATOMYOSITIS | BRISTOL, LYNN ANNE | 53d overdue |
| 18292042 | METHODS OF TREATING COPPER METABOLISM-ASSOCIATED DISEASES OR DISORDERS | RONEY, CELESTE A | 51d overdue |
| 18219138 | ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS | NATARAJAN, MEERA | 38d overdue |
| 18018936 | DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATING HEMATOPOIETIC STEM CELL TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (HSCT-TMA) | SZPERKA, MICHAEL EDWARD | 17d overdue |
| 17784025 | METHODS OF TREATING PREGNANCY-ASSOCIATED ATYPICAL HEMOLYTIC UREMIC SYNDROME USING AN ANTI-C5 ANTIBODY | SZPERKA, MICHAEL EDWARD | 8d overdue |
| 18010076 | METHODS FOR TESTING ANDEXANET POTENCY | FAN, LYNN Y | 5d overdue |
| 17924610 | CIRCULATING B CELL SUBPOPULATIONS IN INDOLENT B CELL LYMPHOMA | SEITZ, ANTHONY JOSEPH | 14d |
| Art Unit | Apps |
|---|---|
| 1643 | 3 |
| 1641 | 3 |
| 1612 | 1 |
| 1615 | 1 |
| 1652 | 1 |
| 1675 | 1 |
| 1759 | 1 |
| 1629 | 1 |
| 1677 | 1 |
| 1758 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18292042 | METHODS OF TREATING COPPER METABOLISM-ASSOCIATED DISEASES OR DISORDERS | RONEY, CELESTE A | 1612 | Other | Non-Final OA | 51d overdue | Pending | Jan 25, 2024 |
| 18272308 | NOVEL FORMULATION FOR TREATING COPPER METABOLISM-ASSOCIATED DISEASES OR DISORDERS | WORSHAM, JESSICA N | 1615 | §103 | Non-Final OA | 39d | Pending | Jul 13, 2023 |
| 18219138 | ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS | NATARAJAN, MEERA | 1643 | §101 | Non-Final OA | 38d overdue | Pending | Jul 07, 2023 |
| 18032973 | METHOD OF CONTROLLING TOTAL SIALIC ACID CONTENT (TSAC) DURING MANUFACTURING OF ALKALINE PHOSPHATASE | RAMIREZ, DELIA M | 1652 | Other | Final Rejection | — | Pending | Apr 20, 2023 |
| 18029525 | METHODS OF TREATING DERMATOMYOSITIS | BRISTOL, LYNN ANNE | 1643 | Other | Non-Final OA | 53d overdue | Pending | Mar 30, 2023 |
| 18018936 | DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATING HEMATOPOIETIC STEM CELL TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (HSCT-TMA) | SZPERKA, MICHAEL EDWARD | 1641 | Other | Non-Final OA | 17d overdue | Pending | Jan 31, 2023 |
| 18011807 | DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATING PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) IN PEDIATRIC PATIENTS | BERHANE, SELAM | 1675 | Other | Non-Final OA | 73d overdue | Pending | Dec 20, 2022 |
| 18010076 | METHODS FOR TESTING ANDEXANET POTENCY | FAN, LYNN Y | 1759 | §103 | Final Rejection | 5d overdue | Pending | Dec 13, 2022 |
| 17924610 | CIRCULATING B CELL SUBPOPULATIONS IN INDOLENT B CELL LYMPHOMA | SEITZ, ANTHONY JOSEPH | 1629 | Other | Non-Final OA | 14d | Pending | Nov 10, 2022 |
| 17923148 | METHOD OF USING EXTRACELLULAR VESICLES TO DETECT COMPLEMENT ACTIVATION, AND USES THEREOF TO ASSESS AND/OR MONITOR TREATMENT OF A COMPLEMENT-MEDIATED DISEASE | MARCSISIN, ELLEN JEAN | 1677 | §112 | Non-Final OA | 26d | Pending | Nov 03, 2022 |
| 17920499 | PROTEIN A CHROMATOGRAPHY PURIFICATION OF AN ANTIBODY | HUANG, MICKEY NMN | 1758 | §103 | Final Rejection | 14d | Pending | Oct 21, 2022 |
| 17838115 | METHOD AND SYSTEM FOR IMPROVED MANAGEMENT OF GENETIC DISEASES | MINCHELLA, KAITLYN L | 1685 | §112 | Non-Final OA | 59d overdue | Pending | Jun 10, 2022 |
| 17784025 | METHODS OF TREATING PREGNANCY-ASSOCIATED ATYPICAL HEMOLYTIC UREMIC SYNDROME USING AN ANTI-C5 ANTIBODY | SZPERKA, MICHAEL EDWARD | 1641 | §103 | Non-Final OA | 8d overdue | Pending | Jun 09, 2022 |
| 17738131 | HIGH CONCENTRATION ANTI-C5 ANTIBODY FORMULATIONS | KIM, YUNSOO | 1641 | Other | Non-Final OA | 19d | Pending | May 06, 2022 |
| 17641907 | METHODS OF MEASURING COPPER CONCENTRATION IN BIOLOGICAL SAMPLES | XU, XIAOYUN | 1797 | §112 | Non-Final OA | 58d overdue | Pending | Mar 10, 2022 |
| 17630601 | METHODS FOR TREATMENT OF REFRACTORY GENERALIZED MYASTHENIA GRAVIS WITH ECULIZUMAB | CHATTIN, AMY MARIE | 1643 | §103 | Final Rejection | 140d overdue | Pending | Jan 27, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial